Ted Schaeffer, M.D.

Ted Schaeffer, an esteemed urologist and author, explores critical issues around prostate health. He discusses natural aging effects, urinary symptoms, and the impacts of medications like finasteride. Schaeffer dives into the complexities of prostate cancer, emphasizing the roles of androgens and genetics in its development. He elaborates on screening methods, including PSA tests and MRIs, and highlights innovative treatment options ranging from surgical interventions to androgen deprivation therapy—all essential insights for proactive prostate health management.

Ted Schaeffer, an esteemed urologist and chair of the Department of Urology at Feinberg School of Medicine, breaks down the nuances of testosterone and its impact on prostate cancer. He discusses insights from the TRAVERSE trial, revealing that testosterone replacement therapy may not significantly increase cancer risk. Schaeffer also explores the androgen receptor saturation theory and introduces the Decipher test for predicting cancer aggressiveness. He shares advancements in precision medicine, emphasizing tailored treatment strategies to optimize patient outcomes.

Ted Schaeffer, M.D., Ph.D., a leading expert in prostate cancer, returns to discuss crucial topics around screening. He breaks down the complexities of prostate-specific antigen (PSA) levels and their implications for health, using vivid analogies for clarity. The conversation also highlights cutting-edge tests like the 4K score and Prostate Health Index (PHI), which improve risk assessment and diagnostics. Schaeffer emphasizes the importance of distinguishing between aggressive and non-aggressive prostate cancers to enhance patient outcomes.